Scynexis Inc SCYX

NAS: SCYX | ISIN: US8112921015   19/04/2024
1,440 USD (+2,49%)
(+2,49%)   19/04/2024
Grafiek Scynexis Inc Grafiek Scynexis Inc

Scynexis Inc in het nieuws

8 januari 2024 · Final SCYX Investor Deadline: Bronstein, Gewirtz & Grossman LLC Announces that SCYNEXIS, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! · Persbericht

4 januari 2024 · SCYX Investors Have Opportunity to Lead SCYNEXIS, Inc. Securities Fraud Lawsuit · Persbericht

28 december 2023 · SCYNEXIS INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Scynexis To Contact Him Directly To Discuss Their Options · Persbericht

21 december 2023 · SCYNEXIS INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Scynexis To Contact Him Directly To Discuss Their Options · Persbericht

15 december 2023 · SCYX Investors Have Opportunity to Lead SCYNEXIS, Inc. Securities Fraud Lawsuit · Persbericht

5 december 2023 · SCYNEXIS SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Scynexis To Contact Him Directly To Discuss Their Options · Persbericht

1 december 2023 · SCYX Investors Have Opportunity to Lead SCYNEXIS, Inc. Securities Fraud Lawsuit · Persbericht

12 november 2023 · ROSEN, TRIAL ATTORNEYS, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYX · Persbericht

4 november 2023 · SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SCYNEXIS, Inc. - SCYX · Persbericht

26 oktober 2023 · SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SCYNEXIS, Inc. - SCYX · Persbericht

Profiel Scynexis Inc

Fabricage van farmaceutische preparaten
Farmaceutische producten: Andere
Gezondheidstechnologie
Productie

Website: www.scynexis.com

Hoofdzetel: Jersey City, New Jersey vlag Verenigde Staten

Werknemers: 81

Aandelen Scynexis Inc

Beurswaarde: 54,37 miljoen USD

Effecten: 37,75 miljoen

Winst per aandeel (12 maand):  PLUS

Koers-winstverhouding:  PLUS

Beta: 1,06

Mijn selecties